Peterson Wealth Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$794K Sell
9,198
-143
-2% -$11.9K 0.17% 85
2026
Q2
$629K Sell
9,341
-6
-0.1% -$400 0.14% 95
2026
Q1
$587K Buy
9,347
+3,808
+69% +$265K 0.15% 89
2025
Q4
$368K Sell
5,539
-23,398
-81% -$1.51M 0.09% 99
2025
Q3
$383K Buy
28,937
+23,410
+424% +$1.85M 0.09% 103
2025
Q2
$482K Buy
5,527
+2,003
+57% +$157K 0.13% 97
2025
Q1
$241K Buy
3,524
+494
+16% +$40.3K 0.07% 115
2024
Q4
$236K Buy
3,030
+201
+7% +$14.9K 0.07% 110
2024
Q3
$190K Buy
+2,829
New +$232K 0.06% 124
2024
Q2
– Sell
-1,543
Closed -$214K – 112
2024
Q1
$214K Buy
+1,543
New +$194K 0.08% 111

Other funds holding DXCM

Peterson Wealth Services's DXCM Position: Q3 2026 in Review

Peterson Wealth Services reduced its DexCom (DXCM) stake by 1.5% in Q3 2026, selling an estimated $11.9K and leaving 9,198 shares worth $794K. The position accounts for 0.17% of the portfolio, ranked #85.

Peterson Wealth Services first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. 516 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Peterson Wealth Services held 9,198 shares of DexCom worth $794K as of Q3 2026.
  • Peterson Wealth Services sold 143 DexCom shares in Q3 2026, an estimated $11.9K.
  • DexCom made up 0.17% of Peterson Wealth Services's portfolio in Q3 2026, its #85 holding.
  • Peterson Wealth Services first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • 516 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Peterson Wealth Services's 13F filing for Q3 2026, filed 26 Oct 2026.